0001702123-25-000002.txt : 20251104 0001702123-25-000002.hdr.sgml : 20251104 20251104161030 ACCESSION NUMBER: 0001702123-25-000002 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: Rule 506(b) provides a "safer harbor" for a private offering FILED AS OF DATE: 20251104 DATE AS OF CHANGE: 20251104 EFFECTIVENESS DATE: 20251104 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Cardiol Therapeutics Inc. CENTRAL INDEX KEY: 0001702123 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] ORGANIZATION NAME: 03 Life Sciences EIN: 000000000 STATE OF INCORPORATION: A6 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-563020 FILM NUMBER: 251449114 BUSINESS ADDRESS: STREET 1: 602-2265 UPPER MIDDLE ROAD EAST CITY: OAKVILLE STATE: A6 ZIP: L6H 0G5 BUSINESS PHONE: 289-910-0850 MAIL ADDRESS: STREET 1: 602-2265 UPPER MIDDLE ROAD EAST CITY: OAKVILLE STATE: A6 ZIP: L6H 0G5 D 1 primary_doc.xml X0708 D LIVE 0001702123 Cardiol Therapeutics Inc. 2265 UPPER MIDDLE ROAD EAST Suite 602 OAKVILLE A6 ONTARIO, CANADA L6H 0G5 289-910-0850 ONTARIO, CANADA None None Corporation true David Elsley 2265 Upper Middle Road East Suite 602 Oakville A6 ONTARIO, CANADA L6H 0G5 Executive Officer Director Chris Waddick 2265 Upper Middle Road East Suite 602 Oakville A6 ONTARIO, CANADA L6H 0G5 Executive Officer Director Andrew Hamer 2265 Upper Middle Road East Suite 602 Oakville A6 ONTARIO, CANADA L6H 0G5 Executive Officer Bernard Lim 2265 Upper Middle Road East Suite 602 Oakville A6 ONTARIO, CANADA L6H 0G5 Executive Officer Guillermo Torre-Amione 2265 Upper Middle Road East Suite 602 Oakville A6 ONTARIO, CANADA L6H 0G5 Director Jennifer Chao 2265 Upper Middle Road East Suite 602 Oakville A6 ONTARIO, CANADA L6H 0G5 Director Teri Loxam 2265 Upper Middle Road East Suite 602 Oakville A6 ONTARIO, CANADA L6H 0G5 Director Peter Pekos 2265 Upper Middle Road East Suite 602 Oakville A6 ONTARIO, CANADA L6H 0G5 Director Colin Stott 2265 Upper Middle Road East Suite 602 Oakville A6 ONTARIO, CANADA L6H 0G5 Director Tim Garnett 2265 Upper Middle Road East Suite 602 Oakville A6 ONTARIO, CANADA L6H 0G5 Director Other Decline to Disclose 06b false 2025-10-17 true true true true true Unit comprised of 1 common share and 1/2 of 1 common share purchase warrant. Each Warrant entitles the holder to purchase 1 additional Share at exercise price of $1.35 per Share for 24-month period from issuance date, subject to an acceleration provision. false 0 8471875 760000 7711875 The additional $7,711,875 may be received upon the exercise of common share purchase warrants sold inside and outside the U.S. false 7 0 0 0 In the ordinary course of business, the issuer may use some of the proceeds of the offering to pay salaries to certain of its executive officers and directors. false Cardiol Therapeutics Inc. /s/ Chris Waddick Chris Waddick Chief Financial Officer 2025-11-04